Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-05

Clinical Trial Update: Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, split-face trial evaluated the efficacy of eflornithine hydrochloride cream for treating melasma; the study has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eflornithine hydrochloride cream (eflornithine hydrochloride)

Snippet

Sponsor: National Skin Centre | Conditions: Melasma | Phase 2 | Status: COMPLETED